MedPath

Intravenous acetaminophen and remifentanil on the airway response in endoscopic sinus surgery

Phase 2
Conditions
cough.
cough
Registration Number
IRCT2014010714199N4
Lead Sponsor
Vice chancellor for research, Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patient's desire to participate in the study and informed consent, ASA1 eligibility criteria, 20-50 years old, Candidate for sinus surgery. Exclusion criteria: Hypertensive, Asthma, Sensitivity to acetaminophen, Sensitivity to narcotic drugs, Chronic obstructive pulmonary disease, A sign of the difficult airway in examination, Aspiration risk, Recent infection of the airways, Chronic cough and liver disorders.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cough. Timepoint: At the end of surgery. Method of measurement: Observation and Minogue grading.
Secondary Outcome Measures
NameTimeMethod
Heart rate. Timepoint: Heart rate was recorded at T0 (When the nasal tampons were inserted by surgeon), at T1 (During normal spontaneous breathing) and at T2 (5 min after tracheal extubation). Method of measurement: Taking the pulse.;The mean arterial pressure. Timepoint: The mean arterial pressure was recorded at T0 (When the nasal tampons were inserted by surgeon), at T1 (During normal spontaneous breathing) and at T2 (5 min after tracheal extubation). Method of measurement: Pressure gauge.
© Copyright 2025. All Rights Reserved by MedPath